Compare FMC Corp (FMC) vs Nucor Corporation (NUE) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

Nucor (NUE) trades at $236.86, up 1.15% today, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $262.89. Recent earnings beat expectations in Q1 2026 with EPS of $3.23 versus $2.82, though Q4 2025 missed. The company maintains a solid balance sheet with $4.14B in cash and a 53-year dividend growth streak, highlighted by a recent $0.56 dividend declaration. Revenue trends show recovery from 2024 lows, with 2025 revenue at $32.49B and net income of $1.74B.

Outlook is positive due to strong analyst buy ratings (62.5%) and projected earnings growth, but risks include cyclical steel demand and margin pressures from high operating costs. The stock offers value with a P/E of 23.5 and ROE of 11.18%, though investors should monitor Q2 2026 results against a $4.42 EPS estimate for continued momentum.